Elite Pharmaceuticals, Inc. Financing Receivable Before Allowance For Credit Loss To Total Percent
Elite Pharmaceuticals, Inc. (ELTP) had Financing Receivable Before Allowance For Credit Loss To Total Percent of 0.54% as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Notes
srt:FinancingReceivableBeforeAllowanceForCreditLossToTotalPercent · last filed 2023-11-14
- 2023-09-30: Financing Receivable Before Allowance For Credit Loss To Total Percent 0.54%.
- 2023-06-30: Financing Receivable Before Allowance For Credit Loss To Total Percent 1.20%.
| Period end | Financing Receivable Before Allowance For Credit Loss To Total Percent |
|---|---|
| 2023-09-30 | 0.54% 10-Q · filed 2023-11-14 |
| 2023-06-30 | 1.20% 10-Q · filed 2023-08-14 |